Karyopharm Therapeutics Inc. - Common Stock (KPTI)

5.8350
+0.2650 (4.76%)
NASDAQ · Last Trade: Apr 1st, 3:44 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026